- Home
- ABSI vs NX Comparison
ABSI vs NX Comparison
Compare ABSI & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABSI | NX |
|---|---|---|
| Founded | 2011 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 819.4M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ABSI | NX |
|---|---|---|
| Price | $9.93 | $20.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $6.96 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 2.5M | 294.8K |
| Earning Date | 05-07-2026 | 06-04-2026 |
| Dividend Yield | N/A | ★ 1.64% |
| EPS Growth | ★ 10.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,534,000.00 | ★ $1,837,641,000.00 |
| Revenue This Year | $215.96 | $4.26 |
| Revenue Next Year | $319.10 | $1.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 43.81 |
| 52 Week Low | $2.24 | $11.04 |
| 52 Week High | $12.06 | $22.90 |
Technical Indicators
Market Signals| Indicator | ABSI | NX |
|---|---|---|
| Relative Strength Index (RSI) | 60.84 | 56.40 |
| Support Level | $2.56 | $15.52 |
| Resistance Level | $12.06 | $21.33 |
| Average True Range (ATR) | 0.57 | 0.83 |
| MACD | 0.13 | -0.07 |
| Stochastic Oscillator | 93.80 | 69.45 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.